Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines

Summary: Several effective SARS-CoV-2 vaccines have been developed using different technologies. Although these vaccines target the isolates collected early in the pandemic, many have protected against serious illness from newer variants. Nevertheless, efficacy has diminished against successive vari...

Full description

Bibliographic Details
Main Authors: Puthupparampil V. Scaria, Chris G. Rowe, Beth B. Chen, Thayne H. Dickey, Jonathan P. Renn, Lynn E. Lambert, Emma K. Barnafo, Kelly M. Rausch, Niraj H. Tolia, Patrick E. Duffy
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:iScience
Subjects:
Immunology
Virology
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222010112

Internet

http://www.sciencedirect.com/science/article/pii/S2589004222010112

Similar Items